Intrastriatal glial cell line-derived neurotrophic factor promotes sprouting of spared nigrostriatal dopaminergic afferents and induces recovery of function in a rat model of parkinson's disease

Neuroscience

Volumn 82, Issue 1, 1997, Pages 129-137

  Rosenblad, C ^a   Martinez Serrano, A ^a   Bjorklund A ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

Autoradiography; GDNF; Hydroxydopamine; Nigrostriatal; Sprouting; Stepping test

Indexed keywords

DOPAMINE; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; OXIDOPAMINE; PIPERIDINE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; FEMALE; MOTOR ACTIVITY; NERVE SPROUTING; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; REINNERVATION; SENSORY NERVE; SUBSTANTIA NIGRA;

ANIMALS; AUTORADIOGRAPHY; DENERVATION; FEMALE; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; IMMUNOHISTOCHEMISTRY; INJECTIONS; MOTOR ACTIVITY; NEOSTRIATUM; NERVE GROWTH FACTORS; NERVE TISSUE PROTEINS; NEURONS, AFFERENT; NEUROPROTECTIVE AGENTS; OXIDOPAMINE; PARKINSON DISEASE, SECONDARY; RATS; RATS, SPRAGUE-DAWLEY; SUBSTANTIA NIGRA; SYMPATHOLYTICS; TYROSINE 3-MONOOXYGENASE;

EID: 0030884756     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(97)00269-8     Document Type: Article

References (26)

1. Beck K. D., Valverde J., Alexi T., Poulsen K., Moffat B., Vandlen R. A., Rosenthal A., Hefti F. Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brain. Nature. 373:1995;339-341.
2. Beck K. D., Irwin I., Valverde J., Brennan T. J., Langston J. W., Hefti F. GDNF induces a dystonia-like state in neonatal rats and stimulates dopamine and seretonin synthesis. Neuron. 16:1996;665-673.
3. Bowenkamp K. E., Hoffman A. F., Gerhardt G. A., Henry M. A., Biddle P. T., Hoffer B. J., Granholm A.-C. E. Glial cell line-derived neurotrophic factor supports survival of injured midbrain dopaminergic neurons. J. comp. Neurol. 355:1995;479-489.
4. Cerruti C., Drian M. J., Kamenka J. M., Privat A. Localization of dopamine carriers by BTCP, a dopamine uptake inhibitor, on nigral cells cultured in vitro. Brain Res. 5551:1991;51-57.
5. Gash D. M., Zhang Z., Ovadia A., Cass W. A., Yi A., Simmerman L., Russell D., Martin D., Lapchak P. A., Collins F., Hoffer B. J., Gerhardt G. A. Functional recovery in Parkinsonian monkeys treated with GDNF. Nature. 380:1996;352-355.
6. Hoffer B. J., Hoffman A., Bowenkamp K., Huettl P., Hudson J., Martin D., Lin L.-F. H., Gerhardt G. A. Glial cell line-derived neurotrophic factror reverses toxin-induced injury to midbrain dopaminergic neurons in vivo. Neurosci. Lett. 182:1994;107-111.
7. Hudson J., Granholm A.-C., Gerhardt G. A., Henry M. A., Hoffman A., Biddle P., Leela N. S., Mackerlova L., Lile J. D., Collins F., Hoffer B. Glial cell line-derived neurotrophic factor augments midbrain dopaminergic circuits in vivo. Brain Res. Bull. 36:1995;425-432.
8. 3H] BTCP: A high-affinity antagonist for the DA uptake complex. Biotech. Update. 7:1992;132-135.
9. Jenkins R., O'Shea R., Thomas K. L., Hunt S. P. c-jun expression in subtantia nigra neurons following striatal 6-hydroxydopamine lesion in the rat. Neuroscience. 53:1993;447-455.
10. Johansson M., Friedemann M., Hoffer B. J., Strömberg I. Effects of glial cell line-derived neurotrophic factor on developing and mature mesencephalic grafts in oculo. Expl Neurol. 134:1995;25-34.
11. Kearns C. M., Gash D. M. GDNF protects nigral dopamine neurons against 6-hydroxydopamine in vivo. Brain Res. 672:1995;104-111.
12. Lee C. S., Sauer H., Björklund A. Dopaminergic neuronal degeneration and motor impairments following lesion by intrastriatal 6-hydroxydopamine in the rat. Neuroscience. 72:1996;641-653.
13. Lin L.-F. H., Doherty D. H., Lile J. D., Bektesh S., Collins F. GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science. 260:1993;1130-1132.
14. Olsson M., Nikkhah G., Bentlage C., Björklund A. Forelimb akinesia in the rat Parkinson model: differential effects of dopamine agonists and nigral transplants assessed by a new stepping test. J. Neurosci. 15:1995;3863-3875.
15. Przedborski S., Levivier M., Jiang H., Ferreira M., Jackson-Lewis V., Donaldson D., Togaski D. M. Dose-dependent lesions of the dopaminergic nigrostriatal pathway induced by intrastriatal injection of 6-hydroxydopamine. Neuroscience. 67:1995;631-647.
16. Rosenblad C., Martinez-Serrano A., Björklund A. Glial cell line-derived neurotrophic factor increases survival, growth and function of intrastriatal fetal nigral dopaminergic grafts. Neuroscience. 75:1996;979-985.
17. Sauer H., Rosenblad C., Björklund A. Glial cell line-derived neurotrophic factor but not transforming growth factor β3 prevents degeneration of nigral dopaminergic neurons following striatal 6-hydroxydopamine lesion. Proc. natn. Acad. Sci. U.S.A. 92:1995;8935-8939.
18. Sauer H., Oertel W. H. Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: a combined retrograde and immunocytochemical study in the rat. Neuroscience. 59:1994;401-415.
19. Shults C. W., Kimber T., Martin D. Intrastriatal injection of GDNF attenuates the effects of 6-hydroxydopamine. NeuroReport. 7:1996;627-631.
20. Sinclair S. R., Svendsen C. N., Torres E. M., Martin D., Fawcett J. W., Dunnett S. B. GDNF enhances dopaminergic cell survival and fibre outgrowth in embryonic nigral grafts. NeuroReport. 7:1996;2547-2552.
21. Strömberg I., Björklund L., Johansson M., Tomac A., Collins F., Olson L., Hoffer B., Humpel C. Glial cell line-derived neurotrophic factor is expressed in the developing but not adult striatum and stimulates developing dopamine neurons in vivo. Expl Neurol. 124:1993;401-412.
22. Tomac A., Lindqvist E., Lin L.-F. H., Ögren S. O., Young D., Hoffer B. J., Olson L. Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo. Nature. 373:1995;335-339.
23. Tomac A., Widefalk J., Lin L.-F. H., Kohno T., Ebendal T., Hoffer B., Olson L. Retrograde axonal transport of glial cell line-derived neurotrophic factor in the adult nigrostriatal system suggests a trophic role in the adult. Proc. natn. Acad. Sci. U.S.A. 92:1995;8274-8278.
24. Ungerstedt U., Arbuthnott G. W. Quantitative recording of rotational behaviour in rats after 6-hydroxydopamine lesions of the nigrostriatal dopamine system. Brain Res. 24:1970;485-493.
25. 3H]-BTCP: a new phencyclidine analog selective for the dopamine uptake complex. Eur. J. Pharmac. 1483:1988;427-436.
26. Winkler C., Sauer H., Lee C. S., Björklund A. Short-term GDNF treatment provides long-term rescue of lesioned nigral dopaminergic neurons in a rat model of Parkinson's disease. J. Neurosci. 1622:1996;7206-7215.